Foley Hoag advised Butterfly Network, while DLA Piper advised the underwriters on the offering. Butterfly Network, Inc. (NYSE: BFLY), a digital health company, announced the registered...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Compass Pathways, while Paul Hastings advised TD Cowen, Cantor, Stifel and RBC Capital Markets as joint book running managers in the offering. Compass...
You must be a Standard 1 Year member to access this content.
Cooley advised Janux Therapeutics, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters related to the transaction, while Latham & Watkins advised the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Forte Biosciences, while Paul Hastings advised TD Cowen in the transaction. Biopharmaceutical company, Forte Biosciences, announced an oversubscribed $53 million...
You must be a Standard 1 Year member to access this content.
Baker McKenzie and K&L Gates advised MdxHealth, while DLA Piper advised TD Cowen on the offering. MdxHealth SA, a commercial-stage precision diagnostics company, announced its public...
You must be a Standard 1 Year member to access this content.
Gornitzky represented the underwriters, led by TD Cowen and Guggenheim Securities on the offering. UroGen Pharma Ltd. secured a USD 107.5 million follow-on public offering of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Monte Rosa Therapeutics, while Paul Hastings advised TD Cowen and Wedbush PacGrow, as joint book-running managers, in the offering. Monte Rosa Therapeutics, Inc....
You must be a Standard 1 Year member to access this content.
Orrick represented TD Cowen and Stifel as joint book-running managers and representatives of several underwriters in the offering. Ichor Holdings, Ltd. executed a $125 million public offering....
You must be a Standard 1 Year member to access this content.
Covington & Burling represented Humacyte, while Paul Hastings advised TD Cowen, Cantor and BTIG in the offering. Humacyte, Inc. executed an underwritten public offering of 13,400,000 shares...
You must be a Standard 1 Year member to access this content.
Paul Hastings LLP advised Jasper Therapeutics, Inc., while DLA Piper advised the underwriters. Jasper Therapeutics, Inc. (Nasdaq: JSPR), a clinical-stage biotechnology company focused on developing novel...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Tenaya Therapeutics on the transaction, and Davis Polk & Wardwell advised the underwriters. Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage...
You must be a Standard 1 Year member to access this content.
Cooley advised Olema Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised TD Cowen, as sales agent. Olema Pharmaceuticals ((“Olema”, Nasdaq: OLMA) announced its $150...
You must be a Standard 1 Year member to access this content.
